Research Attitudes Questionnaire scores predict Alzheimer's disease clinical trial dropout

被引:14
作者
Stites, Shana D. [1 ]
Turner, R. Scott [2 ]
Gill, Jeanine [1 ]
Gurian, Anna [1 ]
Karlawish, Jason [1 ,3 ,4 ,5 ]
Grill, Joshua D. [6 ,7 ]
机构
[1] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA
[2] Georgetown Univ, Dept Neurol, Washington, DC USA
[3] Univ Penn, Penn Memory Ctr, Dept Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Penn Memory Ctr, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA
[5] Univ Penn, Penn Memory Ctr, Dept Neurol, Philadelphia, PA 19104 USA
[6] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Dept Psychiat & Human Behav, 3204 Biol Sci, Irvine, CA 92617 USA
[7] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Dept Neurobiol & Behav, 3204 Biol Sci, Irvine, CA 92617 USA
关键词
Dropout; retention; missingness; DEMENTIA; RECRUITMENT; RETENTION; CONDUCT; BIAS;
D O I
10.1177/1740774520982315
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background Missing data are a notable problem in Alzheimer's disease clinical trials. One cause of missing data is participant dropout. The Research Attitudes Questionnaire is a 7-item instrument that measures an individual's attitudes toward biomedical research, with higher scores indicating more favorable attitudes. The objective of this study was to describe the performance of the Research Attitudes Questionnaire over time and to examine whether Research Attitudes Questionnaire scores predict study dropout and other participant behaviors that affect trial integrity. Methods The Research Attitudes Questionnaire was collected at baseline and weeks 26 and 52 from each member of 119 participant/study partner dyads enrolled in a Phase 2, randomized, double-blind, placebo-controlled mild-to-moderate Alzheimer's disease clinical trial. Within-subject longitudinal analyses examined change in Research Attitudes Questionnaire scores over time in each population. Logistic regression analyses that controlled for trial arm and clustering in trial sites were used to assess whether baseline Research Attitudes Questionnaire scores predicted trial completion, study medication compliance, and enrollment in optional substudies. Results Participants and study partners endorsed statistically similar ratings on the Research Attitudes Questionnaire that were stable over time. Participants with baseline Research Attitudes Questionnaire scores above 28.5 were 4.7 (95% confidence interval = 1.01 to 21.95) times as likely to complete the trial compared to those with lower scores. Applying the same cutoff, baseline study partner Research Attitudes Questionnaire scores were similarly able to predict study completion (odds ratio = 4.2, 95% confidence interval = 1.71 to 10.32). Using a score cutoff of 27.5, higher participant Research Attitudes Questionnaire scores predicted study medication compliance (odds ratio = 5.85, 95% confidence interval = 1.34 to 25.54). No relationship was observed between Research Attitudes Questionnaire score and participation in optional substudies. Conclusion This brief instrument that measures research attitudes may identify participants at risk for behaviors that cause missing data.
引用
收藏
页码:237 / 244
页数:8
相关论文
共 34 条
  • [1] REPORT ON THE 3RD CONSENSUS CONFERENCE ON THE METHODOLOGY OF CLINICAL-TRIALS WITH ANTIPSYCHOTIC-DRUGS
    ANGST, J
    BECH, P
    BOBON, D
    ENGEL, R
    HIPPIUS, H
    JANZEN, GJ
    LECRUBIER, Y
    LINGJAERDE, O
    MOLLER, HJ
    MONTGOMERY, S
    DESOUSA, MP
    ROSSI, A
    SALETU, B
    SEDVALL, G
    STEFANIS, C
    STOLL, KD
    WOGGON, B
    [J]. PHARMACOPSYCHIATRY, 1991, 24 (05) : 149 - 152
  • [2] The relationship between a dementia diagnosis, chronic illness, medicare expenditures, and hospital use
    Bynum, JPW
    Rabins, PV
    Weller, W
    Niefeld, M
    Anderson, GF
    Wu, AW
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (02) : 187 - 194
  • [3] Why are Spousal Caregivers More Prevalent than Nonspousal Caregivers as Study Partners in AD Dementia Clinical Trials?
    Cary, Mark S.
    Rubright, Jonathan D.
    Grill, Joshua D.
    Karlawish, Jason
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2015, 29 (01) : 70 - 74
  • [4] DONEPEZIL TREATMENT OF PATIENTS WITH MCI: A 48-WEEK RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    Crane, Paul K.
    [J]. NEUROLOGY, 2009, 73 (18) : 1514 - +
  • [5] The neuropsychiatric inventory: Assessing psychopathology in dementia patients
    Cummings, JL
    [J]. NEUROLOGY, 1997, 48 (05) : S10 - S16
  • [6] What makes clinical research ethical?
    Emanuel, EJ
    Wendler, D
    Grady, C
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (20): : 2701 - 2711
  • [7] Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33
  • [8] Gardette V, 2007, J NUTR HEALTH AGING, V11, P265
  • [9] RESPONSE AND FOLLOW-UP BIAS IN COHORT STUDIES
    GREENLAND, S
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1977, 106 (03) : 184 - 187
  • [10] Retention of Alzheimer Disease Research Participants
    Grill, Joshua D.
    Kwon, Jimmy
    Teylan, Merilee A.
    Pierce, Aimee
    Vidoni, Eric D.
    Burns, Jeffrey M.
    Lindauer, Allison
    Quinn, Joseph
    Kaye, Jeff
    Gillen, Daniel L.
    Nan, Bin
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2019, 33 (04) : 299 - 306